Let’s break barriers to fight Covid-19 together

Lucense develops viral sample collection device

Singapore-based Lucence said it has developed a sample collection device for viral infections such as COVID-19.

Unlike other companies’ tests, Lucence’s SAFER-Sample (Stabilization of nucleic Acid Formulation for Evaluation of RNA) does not require samples from nose or throat swabs to be chilled for transport to a lab.

It comes with a bottle of stabilization fluid to be mixed with the sample at the point of collection, keeping viral RNA stable at room temperature for up to one week. The sample can then be transported to a testing lab without the need for chilling, especially useful in countries where samples must be transported long distances for testing.

More information

Notify of